Immunovia: Philipp Mathieu

Immunovia has appointed Philipp Mathieu as acting CEO and president while it continues to search for a permanent CEO. Mathieu has extensive experience as an adviser on corporate strategy, mergers and acquisitions, and capital markets transactions to healthcare and life sciences companies in Europe and the US. In November, Lund, Sweden-based Immunovia announced that Patrik Dahlen would step down in 2022 from his position as president and CEO.